AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-3.65%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.36B
AUM Growth
+$3.36B
(-16%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
27.79%
Holding
302
New
82
Increased
55
Reduced
75
Closed
50
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$65.3M |
| 2 |
Immunovant
IMVT
|
$39.8M |
| 3 |
AB InBev
BUD
|
$38.9M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
$33.3M |
| 5 |
Charles River Laboratories
CRL
|
$30.6M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$114M |
| 2 |
Pfizer
PFE
|
$76.9M |
| 3 |
Johnson & Johnson
JNJ
|
$50.7M |
| 4 |
Neurocrine Biosciences
NBIX
|
$48.8M |
| 5 |
Incyte
INCY
|
$42.7M |
Sector Composition
| 1 | Healthcare | 66.93% |
| 2 | Consumer Staples | 12.81% |
| 3 | Technology | 8.13% |
| 4 | Consumer Discretionary | 7.55% |
| 5 | Communication Services | 3.65% |